These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21444644)

  • 1. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
    Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
    Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
    Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
    Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
    Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
    Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
    Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal hypocretin-1 (orexin A) levels in cerebrospinal fluid in patients with idiopathic intracranial hypertension.
    Poca MA; Galard R; Serrano E; Merino MA; Pozo-Rosich P; Solana E; Mestres O; de la Calzada MD; Sahuquillo J
    Acta Neurochir Suppl; 2012; 114():221-5. PubMed ID: 22327697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
    Rejdak K; Papuć E; Grieb P; Stelmasiak Z
    Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
    Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
    Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
    J Affect Disord; 2009 Feb; 113(1-2):179-82. PubMed ID: 18533274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache.
    Steinberg A; Wiklund NP; Brundin L; Remahl AI
    Cephalalgia; 2010 Jun; 30(6):696-702. PubMed ID: 20511209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.
    Sarchielli P; Rainero I; Coppola F; Rossi C; Mancini M; Pinessi L; Calabresi P
    Cephalalgia; 2008 Jul; 28(7):714-22. PubMed ID: 18479471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced CSF hypocretin-1 levels are associated with cluster headache.
    Barloese M; Jennum P; Lund N; Knudsen S; Gammeltoft S; Jensen R
    Cephalalgia; 2015 Sep; 35(10):869-76. PubMed ID: 25492975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
    Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF hypocretin-1 levels are normal in multiple-system atrophy.
    Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S
    Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin (orexin) loss in Alzheimer's disease.
    Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
    Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients.
    Papuć E; Stelmasiak Z; Grieb P; Paweł G; Rejdak K
    Neurosci Lett; 2010 Apr; 474(1):9-12. PubMed ID: 20193740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocretins and primary headaches: neurobiology and clinical implications.
    Rainero I; De Martino P; Pinessi L
    Expert Rev Neurother; 2008 Mar; 8(3):409-16. PubMed ID: 18345971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.